GL1X · GenesisL1 explorer

MolNFT v1 · #163930 · protein

P53 cancer mutant Y220S in complex with small-molecule stabilizer PK9301

6SI3 · Cellular tumor antigen P53: “P53 cancer mutant Y220S in complex with small-molecule stabilizer PK9301”. X-ray diffraction, 2 ligands (LEB, ZN), 7 pockets (best druggability 0.60). MolNFT v1 #163930 on GenesisL1: 3D structure…

PDB
6SI3
Type
protein
Length
395 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Cellular tumor antigen P53
UniProt
P04637
Ligands
LEB, ZN
Pockets
7 · best druggability 0.60

Structure

x-ray diffraction · 2 distinct chains · 9% helix, 33% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ACellular tumor antigen P53protein19710% helix, 33% strandP04637
BCellular tumor antigen P53protein1988% helix, 33% strandP04637

Ligands and binding sites

  • LEB · 1-[7-bromanyl-9-[2,2,2-tris(fluoranyl)ethyl]carbazol-3-yl]-~{N}-methyl-methanamine · ligand · 2 copies · chains A, B
  • ZN · Zinc ion · metal · 2 copies · chains A, B
  • EDO · 1,2-ethanediol · additive · 3 copies · chains A, B
  • GOL · Glycerol · additive · chains B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

7 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13120.600.7833EDO
21290.450.7725empty
3740.430.8119LEB
4760.430.8019LEB
51350.420.7519empty

Interfaces

1 interface between chains.

  • A–B · 326 Ų buried · 0 hydrogen bonds · protein-protein

Compared structures

  • 6SI3 · p53 cancer mutant Y220S in complex with small-molecule stabilizer PK9301 · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.